Furthermore, ROCK1 has been found to be overexpressed in a variety of solid tumors, including glioblastoma (150), melanoma (151), osteosarcoma (152), and hepatocellular carcinoma (153). Here, ROCK1 is linked to hepatocellular carcinoma.